PHF17 (JADE1) Human shRNA Lentiviral Particle (Locus ID 79960)

CAT#: TL302510V

PHF17 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

Product Images

GFP signal was observed under microscope at 48 hours after transduction of TL302510A virus into HEK293 cells. TL302510A virus was prepared using lenti-shRNA TL302510A and TR30037 packaging kit.

• 

  GFP signal was observed under microscope at 48 hours after transduction of TL302510B virus into HEK293 cells. TL302510B virus was prepared using lenti-shRNA TL302510B and TR30037 packaging kit.

• 

  GFP signal was observed under microscope at 48 hours after transduction of [TL302510C] virus into HEK293 cells. [TL302510C] virus was prepared using lenti-shRNA [TL302510C] and TR30037 packaging kit.

• 

  GFP signal was observed under microscope at 48 hours after transduction of [TL302510D] virus into HEK293 cells. [TL302510D] virus was prepared using lenti-shRNA [TL302510D] and TR30037 packaging kit.

Specifications

Product Data

• Locus ID: 79960
• Synonyms: PHF17
• Vector: pGFP-C-shLenti
• Format: Lentiviral particles
• RefSeq: NM_001287437, NM_001287439, NM_001287440, NM_001287441, NM_001287442, NM_001287443, NM_024900, NM_199320, NM_024900.1, NM_024900.2, NM_024900.3, NM_024900.4, NM_199320.2, NM_199320.3, NM_001287441.1, NM_001287437.1, NM_001287439.1, NM_001287440.1, NM_001287442.1, NM_001287443.1, BC032376, BC032376.1, NM_199320.4, NM_001287441.2, NM_001287440.2, NM_001287437.2, NM_001287439.2, NM_024900.5
• UniProt ID: Q6IE81
• Summary: Component of the HBO1 complex which has a histone H4-specific acetyltransferase activity, a reduced activity toward histone H3 and is responsible for the bulk of histone H4 acetylation in vivo. Transcriptional coactivator, it may also promote acetylation of nucleosomal histone H4 by KAT5. Promotes apoptosis. May act as a renal tumor suppressor. Negatively regulates canonical Wnt signaling; at least in part, cooperates with NPHP4 in this function.[UniProtKB/Swiss-Prot Function]
• shRNA Design: These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
• Performance Guaranteed: OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples.
  
  For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred).